Current and Future Clinical Applications of ctDNA in Immuno-Oncology

Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive opportunity to diagnose, characterize, and monitor the disease in individual cancer patients. ctDNA can reflect the actual tumor burden and specific genomic state of disease and thus might serve as a prognostic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Stadler, Julia-Christina, Belloum, Yassine, Deitert, Benjamin, Sementsov, Mark, Heidrich, Isabel, Gebhardt, Christoffer, Keller, Laura, Pantel, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397642/
https://www.ncbi.nlm.nih.gov/pubmed/34815256
http://dx.doi.org/10.1158/0008-5472.CAN-21-1718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397642/
https://www.ncbi.nlm.nih.gov/pubmed/34815256
http://dx.doi.org/10.1158/0008-5472.CAN-21-1718

Ejemplares similares